Dear Mr. Berko: I was looking up Valeant Pharmaceuticals, which has many products, especially in the eye care business. I wear contact lenses and have various eye problems for which my ophthalmologist has prescribed several medications made by Valeant. I just looked up the stock,...
Dear Mr. Berko: In the late 1990s, my wife and I bought a Penn Treaty long-term care insurance policy to pay for future costs of nursing home care, which so far we haven't needed. Our parents needed home health and nursing home care, and twice...
Instead, it's offering free two-day shipping to everyone. Wal-Mart (NYSE:WMT) doesn't think it makes sense to charge its online customers for two-day shipping anymore. The retailer is shutting down its year-and-a-half-old ShippingPass program, a $50-per-year two-day shipping service similar to Amazon (NASDAQ:AMZN) Prime. "In today's world of e-commerce, two-day free shipping...
Donald Trump's plan to impose an import tax on goods from Mexico could affect a wide range of companies. Here are a few that have strong connections south of the border. When Donald Trump was elected president in November, stocks rose as investor optimism grew that...
The Chevy Bolt shows that GM's technology claims should be taken very seriously. Many investors think that autonomous vehicles (AVs), or "self-driving cars," will transform the landscape of the traditional auto business. While I think it's premature to pick winners and losers, it seems clear that...
The coal industry has been hit by even more headwinds, and this time, there's no sign it will be able to recover. The Clean Power Plan is all but dead, and President Donald Trump has promised to bring back coal mining jobs in states like West...
Dear Mr. Berko: Several times in the past couple of months, you've said the Dow Jones industrial average will reach 30,000 in the coming 10 years. You must be smoking a controlled substance, because that would be a 10,000-point increase. The Dow closed above 10,000...
Dear Mr. Berko: I think it was in August that you wrote a short comment about Accelerate Diagnostics. At the time, it was trading at $19. I've been a nurse for nearly 30 years, so I was impressed when I read about Accelerate's platform for...
Celldex, Geron, Halozyme, Lexicon, and Synergy look like good small-cap biotech stocks for investors not afraid to take on risk. Looking to add a few thrills to your investing portfolio? Small-cap biotech stocks should be a good place to start. They come with significant risks, but...
These household brands, and one under-the-radar company, are the hallmarks of dividend consistency. Dividends stocks are the heart and soul of most retirement portfolios. Historically, dividend stocks have handily outperformed non-dividend-paying stocks over the long run, and dividend-paying companies often have time-tested business models that act...
